We have located links that may give you full text access.
Estimated excess deaths due to COVID-19 among the urban population of Mainland China, December 2022 to January 2023.
Epidemiology 2024 January 30
BACKGROUND: Mainland China experienced a major surge in SARS-CoV-2 infections in December 2022-January 2023, but its impact on mortality was unclear given the under-reporting of COVID-19 deaths.
METHODS: Using obituary data from the Chinese Academy of Engineering (CAE), we estimated the excess death rate among senior CAE members by taking the difference between the observed rate of all-cause death in December 2022-January 2023 and the expected rate for the same months in 2017 to 2022 by age groups. We used this to extrapolate an estimate of the number of excess deaths in December 2022-January 2023 among urban dwellers in Mainland China.
RESULTS: In December 2022-January 2023, we estimated excess death rates of 0.94 per 100 persons (95% confidence interval: -0.54, 3.16) in CAE members aged 80-84 years, 3.95 (95% CI: 0.50, 7.84) in 85-89 years, 10.35 (95% CI: 3.59, 17.71) in 90-94 years and 16.88 (95% CI: 0.00, 34.62) in 95 years and older. Using our baseline assumptions, this extrapolated to 917,000 (95% CI: 425,000-1.45 million) excess deaths among urban-dwellers in Mainland China, much higher than the 81,000 in-hospital deaths officially reported from December 9, 2022 to January 30, 2023.
CONCLUSIONS: As in many jurisdictions, we estimate that the COVID-19 pandemic had a much wider impact on mortality than what was officially documented in Mainland China.
METHODS: Using obituary data from the Chinese Academy of Engineering (CAE), we estimated the excess death rate among senior CAE members by taking the difference between the observed rate of all-cause death in December 2022-January 2023 and the expected rate for the same months in 2017 to 2022 by age groups. We used this to extrapolate an estimate of the number of excess deaths in December 2022-January 2023 among urban dwellers in Mainland China.
RESULTS: In December 2022-January 2023, we estimated excess death rates of 0.94 per 100 persons (95% confidence interval: -0.54, 3.16) in CAE members aged 80-84 years, 3.95 (95% CI: 0.50, 7.84) in 85-89 years, 10.35 (95% CI: 3.59, 17.71) in 90-94 years and 16.88 (95% CI: 0.00, 34.62) in 95 years and older. Using our baseline assumptions, this extrapolated to 917,000 (95% CI: 425,000-1.45 million) excess deaths among urban-dwellers in Mainland China, much higher than the 81,000 in-hospital deaths officially reported from December 9, 2022 to January 30, 2023.
CONCLUSIONS: As in many jurisdictions, we estimate that the COVID-19 pandemic had a much wider impact on mortality than what was officially documented in Mainland China.
Full text links
Related Resources
Trending Papers
Revascularization Strategy in Myocardial Infarction with Multivessel Disease.Journal of Clinical Medicine 2024 March 27
Intravenous infusion of dexmedetomidine during the surgery to prevent postoperative delirium and postoperative cognitive dysfunction undergoing non-cardiac surgery: a meta-analysis of randomized controlled trials.European Journal of Medical Research 2024 April 19
The Tricuspid Valve: A Review of Pathology, Imaging, and Current Treatment Options: A Scientific Statement From the American Heart Association.Circulation 2024 April 26
Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows.Endocrine Reviews 2024 April 28
Management of Diverticulitis: A Review.JAMA Surgery 2024 April 18
Interstitial Lung Disease: A Review.JAMA 2024 April 23
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app